share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

辉瑞 | 4:持股变动声明-董事 Quincey James
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心信息
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Additionally, the relationship of Quincey James to Pfizer Inc was not specified, nor was the number of shares held by James after the transaction. This information is typically relevant for investors to assess the potential impact of insider transactions on their investment decisions.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed in the announcement. Additionally, the relationship of Quincey James to Pfizer Inc was not specified, nor was the number of shares held by James after the transaction. This information is typically relevant for investors to assess the potential impact of insider transactions on their investment decisions.
最近,辉瑞公司(Pfizer Inc [PFE])的报告人廓辛·詹姆斯(Quincey James)于2024年6月28日进行了股票交易。公告中未披露涉及的股票数量、股票性质、交易价格以及交易总价值的具体细节。此外,未指明廓辛·詹姆斯与辉瑞公司的关系,也未说明交易后詹姆斯持有的股份数量。投资者通常需要这些信息来评估内幕交易对其投资决策的潜在影响。
最近,辉瑞公司(Pfizer Inc [PFE])的报告人廓辛·詹姆斯(Quincey James)于2024年6月28日进行了股票交易。公告中未披露涉及的股票数量、股票性质、交易价格以及交易总价值的具体细节。此外,未指明廓辛·詹姆斯与辉瑞公司的关系,也未说明交易后詹姆斯持有的股份数量。投资者通常需要这些信息来评估内幕交易对其投资决策的潜在影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息